Related Experiment Video
Updated: Jun 18, 2026
DNA Vector-based RNA Interference to Study Gene Function in Cancer
Published on: June 4, 2012
[Establishment of a lung adenocarcinoma cell line stably expressing small interfering RNA targeting hepatoma-derived
Jie Meng1, Li-Ming Cao, Cheng-Ping Hu
1Department of Respiration, Xiangya Hospital, Central South University, Changsha 410008, China. xw7018@163.com
Objective:
To construct a small interfering RNA (siRNA) expression vector targeting hepatoma-derived growth factor (HDGF) and establish a lung adenocarcinoma cell line stably expressing siRNA-HDGF.
Method:
RT-PCR was used to examine HDGF expression in lung adenocarcinoma samples and the matched adjacent lung tissues, and also in lung adenocarcinoma SPC-A-1 cell line. A recombinant lentivirus shRNA-HDGF vector was constructed and transfected into SPC-A-1 cells via Lipofectamine 2000, and the cells with stable expression of HDGF-siRNA was screened by blasticidin selection. The interference effect of siRNA-HDGF was assessed by real-time PCR.
Results:
Compared to the adjacent lung tissues, lung adenocarcinoma and SPC-A-1 cells showed increased expression of HDGF. The recombinant lentivirus shRNA-HDGF vector was successfully constructed and verified by sequence analysis. siRNA-HDGF recombinants markedly inhibited the expression of HDGF in SPC-A-1 cells.
Conclusion:
HDGF expression increases in lung adenocarcinoma and SPC-A-1 cell lines. The recombinant siRNA-HDGF lentivirus vector can inhibit the expression of HDGF in SPC-A-1 cells.
Insights
Hepatoma-derived growth factor (HDGF) is upregulated in lung adenocarcinoma. A novel siRNA-HDGF lentivirus vector effectively inhibits HDGF expression in lung adenocarcinoma cells, offering a potential therapeutic strategy.
Area of Science:
- Molecular Biology
- Oncology
- Gene Expression Regulation
Context:
- Hepatoma-derived growth factor (HDGF) plays a role in tumor progression.
- HDGF expression is elevated in lung adenocarcinoma tissues and cell lines.
- Targeting HDGF is a potential strategy for lung cancer therapy.
Purpose:
- To construct a small interfering RNA (siRNA) expression vector targeting HDGF.
- To establish a stable lung adenocarcinoma cell line (SPC-A-1) expressing siRNA-HDGF.
- To validate the inhibitory effect of siRNA-HDGF on HDGF expression.
Summary:
- HDGF expression was significantly higher in lung adenocarcinoma samples and SPC-A-1 cells compared to adjacent tissues.
- A recombinant lentivirus shRNA-HDGF vector was successfully constructed and verified.
- Transfection of the vector into SPC-A-1 cells resulted in marked inhibition of HDGF expression, confirmed by real-time PCR.
Impact:
- Demonstrates the successful construction of an siRNA-HDGF lentivirus vector.
- Confirms the inhibitory efficacy of the vector on HDGF expression in lung adenocarcinoma cells.
- Provides a foundation for further research into HDGF as a therapeutic target in lung cancer.
